CXI Advisors’s Thermo Fisher Scientific TMO Stock Holding History

CXI Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$17K	Buy	+51	New	+$15.5K	0.04%	63

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CXI Advisors's TMO Position: Q4 2019 in Review

CXI Advisors opened a new position in Thermo Fisher Scientific (TMO) in Q4 2019: 51 shares worth $17K. The stake represents 0.04% of the portfolio and ranks #63 among its holdings.

1,679 funds tracked by Wall St. Rank hold TMO as of Q4 2019.

CXI Advisors held 51 shares of Thermo Fisher Scientific worth $17K as of Q4 2019.
Thermo Fisher Scientific was a new CXI Advisors position in Q4 2019.
Thermo Fisher Scientific made up 0.04% of CXI Advisors's portfolio in Q4 2019, its #63 holding.
1,679 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2019.

Based on CXI Advisors's 13F filing for Q4 2019, filed 27 Jan 2020.